MoH&FW s virtual workshop on cGMP for Indian pharma industry held
MoH&FW s virtual workshop on cGMP for Indian pharma industry held
15 June 2021 | News Health Ministry has collaborated with WHO, JSS AHER, Indian Pharmaceutical Alliance and partners to provide a unique learning platform
www.shutterstock.com
The third of a series of six virtual workshops on Current Good Manufacturing Practices to support the Indian pharmaceutical industry’s vision of providing world-class quality medical products was inaugurated by Dr Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, Government of India. The third workshop has 125 participants from 40 pharma units.
Union Ministry of Health & Family Welfare (MoH&FW) collaborated with the World Health Organization (WHO), JSS Academy of Higher Education & Research at Mysuru (JSS AHER), and the Indian Pharmaceutical Alliance (IPA).
MoH&FW s virtual workshop on cGMP for Indian pharma industry held biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday
India News: NEW DELHI: Amid multiple states reporting a shortage of Covid-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their produc.
Vaccine shortage: Serum Institute to produce 10 crore doses by August, Bharat Biotech promises 7.8 crore jabs
The sources said the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September.
Share Via Email
| A+A A- By PTI
NEW DELHI: Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday